Pulmonary fibrosis is an enduring and advancing pulmonary interstitial disease caused by
multiple factors that ultimately lead to structural changes in normal lung tissue. Currently …

Background Pulmonary arterial hypertension (PAH) is a fatal disease caused by pulmonary
vascular remodeling, with a high incidence and mortality. At present, many clinical drugs for …

Chronic respiratory diseases are long-term conditions affecting the airways and other lung
components that are characterized by a high prevalence, disability rate, and mortality rate …

Jinshui-Huanxian granules (JHGs), a Chinese herbal compound prescription, have shown a
therapeutic effect in reducing lung tissue damage, improving the degree of pulmonary …

Background The efficacy of flavonoid supplementation in animal models of pulmonary
fibrosis has been demonstrated. Purpose We conducted a systematic review and meta …

Currently, Helicobacter pylori eradication by antibiotic therapy faces various challenges,
including antibiotic resistance, side effects on intestinal commensal bacteria, and patient …

The authors have been invited to serve as Guest Editors for this Research Topic. As a Guest
Editors we are responsible for identifying the emerging trends, highlights the important …

The surface plasmon resonance (SPR) biosensor technology is a novel optical analysis
method for studying intermolecular interactions. Owing to in-depth research on Traditional …

Coronavirus disease 2019 (COVID-19) caused a severe epidemic due to severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). Recent studies have found that patients …

Ethnopharmacological relevance Pulmonary fibrosis (PF) is an irreversible lung disease that
severely affects human respiratory function. Traditionally, the natural plant Quzhou Fructus …